BetterLife Pharma Inc. Files May 2025 6-K Report

Ticker: BETRF · Form: 6-K · Filed: May 30, 2025 · CIK: 1464165

Betterlife Pharma INC. 6-K Filing Summary
FieldDetail
CompanyBetterlife Pharma INC. (BETRF)
Form Type6-K
Filed DateMay 30, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 6-K, foreign-private-issuer, company-update

Related Tickers: BETRF

TL;DR

BetterLife Pharma (BETRF) filed its May 6-K, standard foreign issuer report.

AI Summary

BetterLife Pharma Inc. filed a Form 6-K on May 30, 2025, for the month of May 2025. The company, formerly known as Pivot Pharmaceuticals Inc. and Neurokine Pharmaceuticals Inc., is incorporated in A1 and has its principal executive offices in Vancouver, BC. This filing is a report of a foreign private issuer.

Why It Matters

This filing provides routine updates for investors and regulatory bodies regarding BetterLife Pharma Inc.'s status as a foreign private issuer.

Risk Assessment

Risk Level: low — This filing is a routine report for a foreign private issuer and does not contain significant new financial or operational information.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers required to be filed pursuant to rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, typically providing information that the issuer makes or is required to make public in its home country.

What was BetterLife Pharma Inc. previously known as?

BetterLife Pharma Inc. was formerly known as Pivot Pharmaceuticals Inc. and prior to that, Neurokine Pharmaceuticals Inc.

Where are BetterLife Pharma Inc.'s principal executive offices located?

BetterLife Pharma Inc.'s principal executive offices are located at 1275 West 6th Avenue, #300, Vancouver, BC V6H 1A6.

What is the SIC code for BetterLife Pharma Inc.?

The Standard Industrial Classification (SIC) code for BetterLife Pharma Inc. is 2834, which corresponds to Pharmaceutical Preparations.

When is BetterLife Pharma Inc.'s fiscal year end?

BetterLife Pharma Inc.'s fiscal year ends on January 31.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on May 30, 2025 regarding BetterLife Pharma Inc. (BETRF).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing